Impact of Biophoton Therapy On Patients With Brain Disorders
First Institute of All Medicines, a non-profit organization, is conducting a clinical study to investigate whether biophoton generators may be able to help recover brain and body functions.
Fast Facts
Diagnosed with a Brain Disorder
Have a Caregiver Willing to Support You
18+ Years Old
Conducted in Butler - Greater Pittsburgh, PA
Study Background
We want to know if Biophoton Generator technology can improve the lives of people with brain disorders.
Chronic brain disorders pose significant challenges in the field of healthcare. These disorders encompass a wide range of conditions, such as ischemic stroke, hemorrhagic stroke, traumatic brain injury, Alzheimer’s disease, dementia, or Parkinson’s disease. The complex nature of these disorders, combined with their potential life-threatening consequences, presents hurdles in terms of early diagnosis, effective treatment options, and long-term management.
Furthermore, the intricate anatomy and delicate function of the brain make interventions and surgical procedures particularly challenging. Advancements in research and technology are crucial for addressing these challenges and improving outcomes for individuals affected by brain disorders.
Biophoton technology opens a new window into the fascinating mystery of life and vitality. Humans, like all other living organisms, emit ultra-weak light not detectable by the naked eye. This mysterious light, with a color between ultraviolet and infrared, is investigated with the use of highly sensitive photomultiplier systems.
First Institute of All Medicines, a non-profit organization, is conducting this clinical study to further assess what biophoton generators can do for people with brain disorders.
Study Background
We want to know if Biophoton Generator technology can improve the lives of people with brain disorders.
Chronic brain disorders pose significant challenges in the field of healthcare. These disorders encompass a wide range of conditions, such as ischemic stroke, hemorrhagic stroke, traumatic brain injury, Alzheimer’s disease, dementia, or Parkinson’s disease. The complex nature of these disorders, combined with their potential life-threatening consequences, presents hurdles in terms of early diagnosis, effective treatment options, and long-term management.
Furthermore, the intricate anatomy and delicate function of the brain make interventions and surgical procedures particularly challenging. Advancements in research and technology are crucial for addressing these challenges and improving outcomes for individuals affected by brain disorders.
Biophoton technology opens a new window in the fascinating mystery of life and vitality. Humans, like all other living organisms, emit ultra-weak light not detectable by the naked eye. This mysterious light, with a color between ultraviolet and infrared, is investigated with the use of highly sensitive photomultiplier systems.
First Institute of All Medicines, a non-profit organization, is conducting this clinical study to further assess what biophoton generators can do for people with brain disorders.
Additional Information
The purpose of this study is to verify if the subject with a brain disorder can regain the ability to live on their own, after using Tesla BioHealing® Generators, to energize the brain and other parts of the body daily.
You may qualify for a study if you meet the following criteria.
Inclusion Criteria:
- 18+ years old
- Diagnosed with a brain disorder (e.g., Alzheimer’s disease, traumatic brain injury, Parkinson’s disease)
- Have a caregiver that is willing to support the patient’s full involvement in the study if the patient has a decision-making impairment disability
- Speak English
Exclusion Criteria:
- Untreated or uncontrolled mental illnesses
- Rely on a ventilator
- Have a deep brain stimulator, pacemaker, or any implanted electronic device
- No severe medical conditions that impact study participation (e.g., severe chronic pulmonary disease, history of uncontrolled seizures, acute or chronic infectious illness, severe diabetes, kidney failure, or any end-of-life prognosis)
- Participating in another drug or device trial
- Pregnancy
- Infection with COVID-19
Each participant assigned to the Control Group will receive a set of placebo devices. Each participant assigned to the Treatment Group will receive a set of Biophoton Generators. Each participant will use the Treatment or Control device underneath their bed for at least 8 hours every day for 2 weeks, during sleep, or at any time during the day. Participants are able to walk around the center to visit people or places after they have spent 8 hours in their bed resting.
Other study procedures include:
- Each participant will be guided by study team staff to answer a survey to measure life quality. The survey includes questions about mobility, pain, and activities of daily living.
- Participants will answer mental improvement surveys.
- A study doctor will perform a neuro exam, Bio-well energy test, Falcon ankle-brachial blood flow test, and brain biophoton count test, completed at baseline and weeks 1, 2, 3, 4, or end of study.
- EEG at baseline, weeks 2, 4, or end of the study treatment
Also, if you are placed in a control group at first, then you will be switched after 2 weeks into a treatment group for the remaining 4 weeks. Those participants will continue their testing not only at the 4-week mark but also at the 5 and 6-week mark (which will complete the study testing).
You will be put into a study group by chance, like a coin toss. You have a 1 out of 2 chance of being placed in each group. You cannot choose your study group. You will be assigned a testing day, which is usually the day of your arrival. If you arrive on a Monday, your testing days will be scheduled for every Monday, until the end of the study.
There is no cost for you to participate in our research study. First Institute of All Medicines will cover the cost of stay, excluding travel and meals. Participants are still responsible for their travel and meal expenses.